1.National kidney and urologic diseases information clearinghouse: Kidney statistics for the United States 2. United States Renal Data System. USRDS.

Slides:



Advertisements
Similar presentations
Age-Adjusted Prevalence of Diagnosed Diabetes Among U.S. Adults
Advertisements

UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
Chapter 7: Pediatric ESRD 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
CHRONIC KIDNEY DISEASE The Philippine Situation
USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.
Stages of CKD – KDOQI 2002 Definitions
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 5: Acute Kidney Injury 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Diabetic Microvascular Disease: The Role of Glycemic Control and the Impact on Public Health Robert E. Ratner, MD MedStar Research Institute Georgetown.
Chapter 3: Morbidity & Mortality 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Diabetes and PVD.
Glucose Levels and Risk of Dementia Presented by - Anas Kabaha, MD Sheba medical center Sheba medical center August 8,2013.
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
Multiple Choice Questions for discussion
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
Complete Recovery of Renal Function After Acute Kidney Injury is Associated with Long-Term All-Cause Mortality In a Large Managed Care Organization Jennifer.
Why don’t indigenous dialysis patients receive transplants – waitlist or allocation? N. Khanal 1, P. Clayton 1, S. McDonald 1, M. Jose 2 1 The University.
CHRONIC KIDNEY DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Mrs. Watcharasa Pitug ID The Association between Waist Circumference and Renal Insufficiency among Hypertensive Patients 15/10/58 1.
Healthy People 2010 Focus Area 4
Introduction to Statistical Computing Methods in Clinical Research July 2000.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
Chapter 10 Cancer 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Cancer Working.
HEART-LUNG TRANSPLANTATION Adult Recipients JHLT Oct; 32(10):
Chapter 3 Mortality in End Stage Kidney Disease 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 10: Dialysis Providers.
Chapter 5: Acute Kidney Injury 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.
Long-term mortality and thrombolysis therapy after a first acute ischemic stroke: gender differences. Ebrictus II Study. Authors & Affiliations Clua-Espuny.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 4: Vascular Access.
Date of download: 5/28/2016 From: Association Between Exposure to Low to Moderate Arsenic Levels and Incident Cardiovascular Disease: A Prospective Cohort.
Date of download: 5/29/2016 From: The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow- up of the Modification.
Acute Renal Failure in HIV- Infected Individuals Greatly Increases Risk for In-Hospital Mortality Slideset on: Wyatt CM, Arons RR, Klotman PE, Klotman.
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
Date of download: 6/22/2016 From: Biomarkers of Inflammation and Thrombosis as Predictors of Near-Term Mortality in Patients with Peripheral Arterial Disease:
Introduction Data Statistical Methods Table 1: Prevalence of Prior Hip Fracture and Incidence of New Hip Fractures and Fractures of Any Type.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Scope of Coronary Heart Disease in Patients With.
Date of download: 7/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Fibroblast Growth Factor 23 and Risks of Mortality.
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
2016 Annual Data Report, Vol 2, ESRD, Ch 5
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
First-year death rates by modality figure 8
UK Renal Registry 10th Annual Report 2007
Volume 2: End-Stage Renal Disease
December 31st point prevalent counts by modality figure 3.1
UK Renal Registry 18th Annual Report
Influence of Body Mass Index on Long-Term Survival After Cardiac Catheterization  Barak Zafrir, MD, Ronen Jaffe, MD, Ronen Rubinshtein, MD, Basheer Karkabi,
Diabetic Kidney Disease: An ACEI (or an ARB) in the Hole
Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )
Volume 2: End-Stage Renal Disease
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
UK Renal Registry 14th Annual Report
Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing?  Gautam R. Shroff, Charles A. Herzog 
Management of Heart Failure in Advancing CKD: Core Curriculum 2018
Trichopoulou A, et al. BMJ 2009;338:b2337
Expanding the Recognition and Assessment of Bleeding Events Associated With Antiplatelet Therapy in Primary Care  Marc Cohen, MD  Mayo Clinic Proceedings 
2013 Annual Report - 36th Edition
Melissa Herrin, Jan Tate ScD, MPH & Amy Justice, MD, PhD
Christina L. Klein, MD, Daniel C. Brennan, MD, FACP 
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Volume 87, Issue 3, Pages (March 2015)
Worldwide incidence of ESRD figure 12.1, per million population
Time-related mortality for women after coronary artery bypass graft surgery: a population-based study  Veena Guru, MD, Stephen E Fremes, MD, MSc, Jack.
Figure Prevalence of coronary artery disease by year or
Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.
Presentation transcript:

1.National kidney and urologic diseases information clearinghouse: Kidney statistics for the United States 2. United States Renal Data System. USRDS 2007 Annual Data Report. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, U.S. Department of Health and Human Services; National kidney and urologic diseases information clearinghouse: Kidney disease of diabetes

1.National kidney foundation : diabetes and kidney disease; 2.National kidney and urologic diseases information clearinghouse: Kidney statistics for the United State 3.Érika B Rangel, João R de Sá, Cláudio S Melaragno, Adriano M Gonzalez, Marcelo M Linhares, Alcides Salzedas and José O Medina-Pestana. Kidney transplant in diabetic patients: modalities, indications and results. Diabetology & Metabolic Syndrome 2009, 1:2 doi: /

1. National kidney and urologic diseases information clearinghouse: Kidney disease of diabetes

Participant characteristics TABLE 1.PREVALENCE OF KIDNEY TRANSPLANTATION AND MORTALITY BY KIDNEY TRANSPLANTATION N=658%(N)Mortality(%,n)p-value No kidney transplant 90.58(596)22.65(135) Kidney transplant 1 kidney transplant 2 kidney transplant 9.42(62) 83.87(52/62) 16.13(10/62) 46.77(29) 48.08(25) 40.00(4) < TABLE 2.CAUSE OF DEATH IN THOSE WITH KIDNEY TRANSPLANTATION N=28%(N) Diabetic renal disease 21.43(6) Acute complications 10.71(3) Coronary artery disease 46.43(13) Infections 17.86(5) Other- diabetes 3.57(1)

CharacteristicTotal (n=658) No kidney transplant(n=596) kidney transplant(n=62) p-value Age (years)27.03(21.92,33.31)26.5(21.47,32.94)31.9(26.5,35.4) Sex, N(%) Men Women 333(51) 325(49) 298(50) 35(56.45) 27(43.55) Duration of diabetes(years) 18.5(13.23,25.5)18.17(12.73,24.79)24.37(18.5,28.44) BMI(kg/m2) 23.33(21.36,25.44)23.36(21.34,25.49)22.79(21.55,24.86) SBP(mmHg)111(104,121)110(103,119)124.5(116,137)<.0001 DBP(mmHg)72(66,79)71(65,79) 80.5(74,91)<.0001 WBC(cells/mm3)6.2(5.3,7.6)6.2(5.3,7.4)6.9(5.7,8.6) Total cholesterol(mg/dl) 184(162,215)182(161,212)208.5(173,247) HDL(mg/dl)52.2(45.1,60.8)52.55(45.5,60.95)48.1(41.4,56.9) LDL(mg/dl)110.8(91.8,133.6)109.8(90.6,131.4)131(107.8,161.6) Triglycerides(mg/ dl) 83(61,126)80(59,118)127(81,182) Albumin excretion rate( μ g/min) 16.49(7.55,168.56)13.68(7.2,89.67)711.19(100.8,1808.6)<.0001 Table 3. Population characteristics by kidney transplantation [median(q1,q3)]

Table 4: Characteristics of participants who underwent kidney transplantation by subsequent survival status Data are median (q1,q3) for normally distributed and mean(SD) for non normal continuous variables

Table 5:Age adjusted hazard ratios for mortality risk among participants with one or more Kidney transplant *log transformed ^not adjusted for age

*Model adjusted for age, DBP